Search research articles
Contact Us
Filters
Showing results (81-90 of 91) with videos related to
Page
of 10
Sort By:
JAMA Cardiology
|
October 4, 2023
Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial
Amber Sleem, Mark B Effron, Amanda Stebbins, et al.
The New England Journal of Medicine
|
May 24, 2008
Facilitated PCI in patients with ST-elevation myocardial infarction
Stephen G Ellis, Michal Tendera, Mark A de Belder, et al.
American Heart Journal
|
June 8, 2023
Comparison of the effectiveness and safety of 2 aspirin doses in secondary prevention of cardiovascular outcomes in patients with chronic kidney disease: A subgroup analysis of ADAPTABLE
Kamal Gupta, Harsh Mehta, Hwasoon Kim, et al.
Contemporary Clinical Trials
|
July 27, 2025
Association of study visit interval length with follow-up completeness and adherence to assigned study drug dose: A randomized comparison of participants in the ADAPTABLE trial
Dennis I Narcisse, Jeff Whittle, Grace M Rhodes, et al.
American Heart Journal
|
March 5, 2013
TransRadial Education and Therapeutics (TREAT): shifting the balance of safety and efficacy of antithrombotic agents in percutaneous coronary intervention: a report from the Cardiac Safety Research Consortium
Connie N Hess, Sunil V Rao, David F Kong, et al.
Journal of the American Heart Association
|
February 13, 2024
Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease
Guillaume Marquis-Gravel, Amanda Stebbins, Lisa M Wruck, et al.
JAMA Cardiology
|
March 19, 2020
Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial
Guillaume Marquis-Gravel, Matthew T Roe, Holly R Robertson, et al.
Journal of the American Geriatrics Society
|
April 21, 2023
Pragmatic evaluation of events and benefits of lipid lowering in older adults (PREVENTABLE): Trial design and rationale
Jacob Joseph, Nicholas M Pajewski, Rowena J Dolor, et al.
The New England Journal of Medicine
|
May 17, 2021
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease
W Schuyler Jones, Hillary Mulder, Lisa M Wruck, et al.
The New England Journal of Medicine
|
August 5, 2021
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
, , , et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 91) with videos related to
Sort By:
Page
of 10
JAMA Cardiology
|
October 4, 2023
Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial
Amber Sleem, Mark B Effron, Amanda Stebbins, et al.
The New England Journal of Medicine
|
May 24, 2008
Facilitated PCI in patients with ST-elevation myocardial infarction
Stephen G Ellis, Michal Tendera, Mark A de Belder, et al.
American Heart Journal
|
June 8, 2023
Comparison of the effectiveness and safety of 2 aspirin doses in secondary prevention of cardiovascular outcomes in patients with chronic kidney disease: A subgroup analysis of ADAPTABLE
Kamal Gupta, Harsh Mehta, Hwasoon Kim, et al.
Contemporary Clinical Trials
|
July 27, 2025
Association of study visit interval length with follow-up completeness and adherence to assigned study drug dose: A randomized comparison of participants in the ADAPTABLE trial
Dennis I Narcisse, Jeff Whittle, Grace M Rhodes, et al.
American Heart Journal
|
March 5, 2013
TransRadial Education and Therapeutics (TREAT): shifting the balance of safety and efficacy of antithrombotic agents in percutaneous coronary intervention: a report from the Cardiac Safety Research Consortium
Connie N Hess, Sunil V Rao, David F Kong, et al.
Journal of the American Heart Association
|
February 13, 2024
Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease
Guillaume Marquis-Gravel, Amanda Stebbins, Lisa M Wruck, et al.
JAMA Cardiology
|
March 19, 2020
Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial
Guillaume Marquis-Gravel, Matthew T Roe, Holly R Robertson, et al.
Journal of the American Geriatrics Society
|
April 21, 2023
Pragmatic evaluation of events and benefits of lipid lowering in older adults (PREVENTABLE): Trial design and rationale
Jacob Joseph, Nicholas M Pajewski, Rowena J Dolor, et al.
The New England Journal of Medicine
|
May 17, 2021
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease
W Schuyler Jones, Hillary Mulder, Lisa M Wruck, et al.
The New England Journal of Medicine
|
August 5, 2021
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
, , , et al.
Page
of 10